Flygare Anna-Lena, Engström Ingemar, Hasselgren Mikael, Jansson-Fröjmark Markus, Frejgrim Rikard, Andersson Gerhard, Holländare Fredrik
Centre for Clinical Research, Region Värmland, Älvgatan 49, Karlstad, Sweden.
University Health Care Research Centre, Faculty of Medicine and Health, Örebro University, 70116 Örebro, Sweden.
Internet Interv. 2019 Dec 29;19:100303. doi: 10.1016/j.invent.2019.100303. eCollection 2020 Mar.
Internet-based cognitive behavior therapy (ICBT) has proved effective in reducing mild to moderate depressive symptoms. However, only a few studies have been conducted in a regular healthcare setting which limits the generalizability of the results. The influence of psychiatric comorbidity on outcome is not well understood. In the current study, patients with mild to moderate depressive symptoms in primary and psychiatric care were interviewed using the SCID-I and SCID-II to assess psychiatric diagnoses. Those included were randomly allocated to ICBT ( = 48) or to an active control condition ( = 47). Both groups received therapist support. At post-treatment, ICBT had reduced depressive symptoms on the BDI-II more than the active control intervention ( = .021). However, the difference between groups was no longer significant at the 6-, 12- or 24-month follow-ups. The within-group effect size after ICBT (BDI-II) was large ( = 1.4). A comorbid anxiety disorder didn't moderate the outcome, while the presence of a personality disorder predicted significantly less improvement in depressive symptoms. ICBT had a large effect on depressive symptoms in a sample from regular healthcare. It is possible to obtain a large effect from ICBT despite comorbid anxiety, however, including patients with a comorbid personality disorder in the current form of ICBT seems questionable.
基于互联网的认知行为疗法(ICBT)已被证明在减轻轻度至中度抑郁症状方面有效。然而,在常规医疗环境中进行的研究较少,这限制了研究结果的普遍性。精神共病对治疗结果的影响尚不清楚。在当前的研究中,使用《精神疾病诊断与统计手册》第一版(SCID-I)和第二版(SCID-II)对初级和精神科护理中患有轻度至中度抑郁症状的患者进行访谈,以评估精神疾病诊断。纳入的患者被随机分配到ICBT组(n = 48)或积极对照组(n = 47)。两组均接受治疗师的支持。治疗后,ICBT组在贝克抑郁量表第二版(BDI-II)上的抑郁症状减轻程度超过了积极对照干预组(p = .021)。然而,在6个月、12个月或24个月的随访中,两组之间的差异不再显著。ICBT组(BDI-II)的组内效应量很大(Cohen's d = 1.4)。共病焦虑症并未调节治疗结果,而人格障碍的存在预示着抑郁症状的改善明显较少。ICBT对常规医疗样本中的抑郁症状有很大影响。尽管存在共病焦虑,但ICBT仍可能产生很大的效果,然而,将共病性人格障碍患者纳入当前形式的ICBT似乎存在问题。